Etoposide Suppliers & Bulk Manufacturers

Available Forms: Oral Capsules & Injection:

Available Strengths: Injection: 20 mg/mL; Capsule: 50 mg

Reference Brands: US: Toposar® (injection) VePesid® (capsules); EU: Etopophos® (injectable phosphate form) Vepesid® (capsules)

Category: Oncology Cancer Care

Etoposide is available in Oral Capsules & Injection: and strengths such as Injection: 20 mg/mL; Capsule: 50 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Etoposide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Etoposide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Etoposide is a potent oncology agent available in the US and EU, widely used to treat small cell lung cancer, testicular cancer, and various hematologic malignancies. Available as 20 mg/mL injection and 50 mg oral capsules, Etoposide disrupts DNA replication by inhibiting topoisomerase II, leading to cancer cell death. Sold under brand names like Toposar®, VePesid®, and Etopophos®, and as numerous generics, it remains a cornerstone in combination chemotherapy protocols. Etoposide is a trusted and essential option in hospital procurement and pharmaceutical B2B supply chains across regulated markets.